INT-767 improves histopathological features in a diet-inducedob/obmouse model of biopsy-confirmed non-alcoholic steatohepatitis-Reference-Cited by-同舟云学术

INT-767 improves histopathological features in a diet-inducedob/obmouse model of biopsy-confirmed non-alcoholic steatohepatitis

Published:2018-01-14 Issue:2 Volume:24 Page:195-210
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:
Short-container-title:WJG

Author:

Roth Jonathan D,Feigh Michael,Veidal Sanne S,Fensholdt Louise KD,Rigbolt Kristoffer T,Hansen Henrik H,Chen Li C,Petitjean Mathieu,Friley Weslyn,Vrang Niels,Jelsing Jacob,Young Mark

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference35 articles.

1. Review Team, LaBrecque DR, Abbas Z, Anania F, Ferenci P, Khan AG, Goh KL, Hamid SS, Isakov V, Lizarzabal M, Peñaranda MM, Ramos JF, Sarin S, Stimac D, Thomson AB, Umar M, Krabshuis J, LeMair A; World Gastroenterology Organisation. World Gastroenterology Organisation global guidelines: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. J Clin Gastroenterol 2014; 48: 467-473

2. Nonalcoholic fatty liver disease: From steatosis to cirrhosis

3. Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation

4. Identification of membrane-type receptor for bile acids (M-BAR)

5. A G Protein-coupled Receptor Responsive to Bile Acids

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathophysiological Relationship between Type 2 Diabetes Mellitus and Metabolic Dysfunction-Associated Steatotic Liver Disease: Novel Therapeutic Approaches;International Journal of Molecular Sciences;2024-08-10

2. Thrombospondin 2, matrix Gla protein and digital analysis identified distinct fibroblast populations in fibrostenosing Crohn’s disease;Scientific Reports;2024-06-14

3. Inflammation in Steatotic Liver Diseases: Pathogenesis and Therapeutic Targets;Seminars in Liver Disease;2024-06-05

4. Regulating bile acids signaling for NAFLD: molecular insights and novel therapeutic interventions;Frontiers in Microbiology;2024-06-03

5. Increased hepatoprotective effects of the novel farnesoid X receptor agonist INT-787 versus obeticholic acid in a mouse model of nonalcoholic steatohepatitis;PLOS ONE;2024-04-25